Home ⟩ Insights

Insights

price-target

4 min read • August 6, 2021

Cantor Fitzgerald Lowers Price On Trulieve Cannabis Corp Ahead Of Q2 Report, Still Among Top US Picks

1 min read • August 5, 2021

Needham Maintains Buy on Trulieve Cannabis, Raises Price Target to $68.25

1 min read • July 14, 2021

Desjardins Initiates Coverage On IM Cannabis with Buy Rating, Announces Price Target of C$10.5

1 min read • July 7, 2021

Jefferies Initiates Coverage On Trulieve Cannabis with Buy Rating, Announces Price Target of $62

1 min read • June 10, 2021

Alliance Global Partners Initiates Coverage On IM Cannabis with Buy Rating, Announces Price Target of $10

1 min read • May 14, 2021

Cantor Fitzgerald Maintains Neutral on Aurora Cannabis, Lowers Price Target to C$9

1 min read • May 14, 2021

Canaccord Genuity Downgrades Aurora Cannabis to Sell, Lowers Price Target to C$7

1 min read • May 14, 2021

BMO Capital Upgrades Aurora Cannabis to Market Perform, Lowers Price Target to C$8

1 min read • May 14, 2021

Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Lowers Price Target to $71

1 min read • May 11, 2021

CIBC Downgrades Aurora Cannabis to Underperformer, Lowers Price Target to C$9

1 min read • May 10, 2021

Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Lowers Price Target to $76

1 min read • April 30, 2021

Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Raises Price Target to $89

Latest Headlines

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.